Lusarin, Normalita F.
HRN: 08-89-00 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/27/2026
CEFTRIAXONE 1G (VIAL)
07/27/2026
08/03/2026
IV
2g
OD
CAPMR
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: